These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17112161)

  • 1. [Increasing cost of insulin therapy in Belgium. From a critical analysis of the situation to a search for practical solutions].
    Scheen AJ
    Rev Med Liege; 2006 Sep; 61(9):617-22. PubMed ID: 17112161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in diabetic patients' pharmacotherapy in Bulgaria.
    Valov V; Doneva M; Borisova AM; Tankova T; Czech M; Manova M; Savova A; Peikova L; Petrova G
    Eur Rev Med Pharmacol Sci; 2014; 18(10):1499-506. PubMed ID: 24899609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics of insulin.
    Shah SN
    J Assoc Physicians India; 2007 Jul; 55 Suppl():67-70. PubMed ID: 17927015
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of treatment and complications of adult type 1 diabetes.
    Franciosi M; Lucisano G; Amoretti R; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Vitacolonna E; Nicolucci A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):606-11. PubMed ID: 22749531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes costs rise, but so does adherence.
    Manag Care; 2005 Apr; 14(4):54. PubMed ID: 15898213
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
    Lüddeke HJ
    MMW Fortschr Med; 2006 Sep; 148(37):9. PubMed ID: 17036893
    [No Abstract]   [Full Text] [Related]  

  • 15. The diabetic day-care unit. II. Comparison of patients and costs of initiating insulin therapy in the unit and a hospital.
    Spaulding RH; Spaulding WB
    Can Med Assoc J; 1976 May; 114(9):780-3. PubMed ID: 1268789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin analogues--which dimension should be discussed?].
    Verspohl EJ
    Med Monatsschr Pharm; 2006 Jun; 29(6):198-9. PubMed ID: 16792195
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin therapy and exercise.
    Kourtoglou GI
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S73-7. PubMed ID: 21864755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.